Type 2 diabetes mellitus with pancreatic β cell dysfunction in 3 horses confirmed with minimal model analysis

Equine Veterinary Journal

Volumn 41, Issue 9, 2009, Pages 924-929

  Durham, A E ^a   Hughes, K J ^b   Cottle, H J ^b   Rendle, D I ^a,d   Boston, R C ^c  

^a LIPHOOK EQUINE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d Western Counties Equine Clinic   (United Kingdom)

Author keywords

Diabetes mellitus; Frequently sampled intravenous glucose tolerance test; Horse; Insulin resistance; Minimal model

Indexed keywords

ANTIDIABETIC AGENT; GLIBENCLAMIDE; METFORMIN;

ANIMAL; ANIMAL DISEASE; ANIMAL FOOD; ARTICLE; CASE REPORT; DIET; DIET THERAPY; FEMALE; GLUCOSE TOLERANCE TEST; HORSE; HORSE DISEASE; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL;

ANIMAL FEED; ANIMALS; DIABETES MELLITUS, TYPE 2; DIET; DIET THERAPY; FEMALE; GLUCOSE TOLERANCE TEST; GLYBURIDE; HORSE DISEASES; HORSES; HYPOGLYCEMIC AGENTS; INSULIN-SECRETING CELLS; MALE; METFORMIN;

EID: 77951913887     PISSN: 04251644     EISSN: 20423306     Source Type: Journal    
DOI: 10.2746/042516409X452152     Document Type: Article

References (55)

1. Anon (1999) Definition, diagnosis and classification of diabetes mellitus and its complications: Report of a WHO consultation. Part 1: Diagnosis and classification of diabetes mellitus. World Health Organisation, Geneva .
2. Anon (2003) American Diabetes Association. Economic costs of diabetes in the US in 2002. Diabetes Care 26, 917-932.
3. Anon (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Report of a WHO/IDF consultation. World Health Organisation, Geneva .
4. Anon (2007) United States Department of Agriculture Equine 2005 Part II: Changes in the U.S. Equine Industry, 1998-2005. http:nahms.aphis.usda.govequineequine05equine05part2trends.pdf.
5. Aronne, L.J. (2007) Therapeutic options for modifying cardiometabolic risk factors. Am. J. Med. 120, S26-34.
6. Asplin, K.E., Sillence, M.N., Pollitt, C.C. and McGowan, C.M. (2007) Induction of laminitis by prolonged hyperinsulinaemia in clinically normal ponies. Vet. J. 174, 530-535.
7. Baker, J.R. and Ritchie, H.E. (1974) Diabetes mellitus in the horse: a case report and review of the literature. Equine vet. J. 6, 7-11.
8. Boston, R.C., Stefanovski, D., Moate, P.J., Sumner, A.E., Watanabe, R.M. and Bergman, R.N. (2003) MINMOD Millennium: a computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test. Diabetes Technol. Ther. 5, 1003-1015.
9. Bulgin, M.S. and Anderson, B.C. (1983) Verminous arteritis and pancreatic necrosis with diabetes mellitus in a pony. Comp. cont. Educ. pract. Vet. 5, S482-S485.
10. Donner, T.W. (2006) Tight control of hyperglycaemia in type 2 diabetes mellitus. Insulin 1, 166-172.
11. Durham, A.E., Rendle, D.I. and Newton, J.R. (2008) The effect of metformin on measurements of insulin sensitivity and β-cell response in 18 horses and ponies with insulin resistance. Equine vet. J. 40, 493-500.
12. Eiler, H., Frank, N., Andrews, F.M., Oliver, J.W. and Fecteau, K.A. (2005) Physiologic assessment of blood glucose homeostasis via combined intravenous glucose and insulin testing in horses. Am. J. vet. Res. 66, 1598-604.
13. Field, J.R. and Wolf, C. (1988) Cushing's syndrome in a horse. Equine vet. J. 20, 301-304.
14. Firshman, A.M. and Valberg, S.J. (2007) Factors affecting clinical assessment of insulin sensitivity in horses. Equine vet. J. 39, 567-575.
15. Frank, N., Elliott S.B. and Boston, R.C. (2008) Effects of long-term oral administration of levothyroxine sodium on glucose dynamics in healthy adult horses. Am. J. vet. Res. 69, 76-81.
16. Garber, A.J., Larsen, J., Schneider, S.H., Piper, B.A. and Henry, D. (2002) Simultaneous glyburide/metformin therapy is superior to component monotherapy as an initial pharmacological treatment for type 2 diabetes. Diabetes Obes. Metab. 4, 201-208.
17. Hess, T.M., Treiber, K.H., Kronfeld, D.S. and Furr, M.O. (2006) Insulin resistance demonstrated by a specific quantitative method in a hyperlipaemic laminitic pony. J. equine vet. Sci. 26, 271-274.
18. Hillyer, M.H., Taylor, F.G.R., Mair, T.S., Murphy, D., Watson, T.D.G. and Love, S. (1992) Diagnosis of hyperadrenocorticism in the horse. Equine vet. Educ. 4, 131-134.
19. Hoffman, R.M., Boston, R.C., Stefanovski, D., Kronfeld, D.S. and Harris, P.A. (2003) Obesity and diet affect glucose dynamics and insulin sensitivity in Thoroughbred geldings. J. anim. Sci. 81, 2333-2342.
20. Holscher, M.A., Linnabary, R.L., Netsky, M.G. and Owen, H.D. (1978) Adenoma of the pars intermedia and hirsutism in a pony. Vet. Med. small. anim. Clin. 73, 1197-1200.
21. Jeffrey, J.R. (1968) Diabetes mellitus secondary to chronic pancreatitis in a pony. J. Am. vet. med. Ass. 153, 1168-1175.
22. Johnson, P.J., Scotty, N.C., Wiedmeyer, C., Messer, N.T. and Kreeger, J.M. (2005) Diabetes mellitus in a domesticated Spanish mustang. J. Am. vet. med. Ass. 226, 584-588, 542.
23. Kahn, S.E. (2000) The importance of the δ-cell in the pathogenesis of type 2 diabetes mellitus. Am. J. Med. 108, 2S-8S.
24. Kahn, S.E. (2001) The importance of beta-cell failure in the development and progression of type 2 diabetes. J. clin. Endocrinol. Metab. 86, 4047-4058.
25. Kahn, S.E. (2003) The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 46, 3-19.
26. King, J.M., Kavanaugh, J.F. and Bentinck-Smith, J. (1962) Diabetes mellitus with pituitary neoplasms in a horse and a dog. Cornell Vet. 52, 133-145.
27. Knowler, W.C., Barrett-Connor, E., Fowler, S.E., Hamman, R.F., Lachin, J.M., Walker, E.A. and Nathan, D.M. (2002) Diabetes prevention program research group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. Med. 346, 393-403.
28. Kronfeld, D.S., Treiber, K.H. and Geor, R.J. (2005) Comparison of nonspecific indications and quantitative methods for the assessment of insulin resistance in horses and ponies. J. Am. vet. med. Ass. 226, 712-719.
29. Loeb, W.F., Capen, C.C. and Johnson, L.E. (1966) Adenomas of the pars intermedia associated with hyperglycemia and glycosuria in two horses. Cornell Vet. 56, 623-639.
30. Martin, B.C., Warram, J.H., Krolewski, A.S., Bergman, R.N., Soeldner, J.S. and Kahn, C.R. (1992) Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 340, 925-929.
31. McCoy, D.J. (1986) Diabetes mellitus associated with bilateral granulosa cell tumors in a mare. J. Am. vet. med. Ass. 188, 733-735.
32. Muniyappa, R., Lee, S., Chen, H. and Quon, M.J. (2008) Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am. J. Physiol. Endocrinol. Metab. 294, E15-26.
33. Muñoz, M.C., Doreste, F., Ferrer, O., González, J. and Montoya, J.A. (1996) Pergolide treatment for Cushing's syndrome in a horse. Vet. Rec. 139, 41-43.
34. Murphy, D., Reid, S.W., Graham, P.A. and Love, S. (1997) Fructosamine measurement in ponies: validation and response following experimental cyathostome infection. Res. vet. Sci. 63, 113-118.
35. Muylle, E., van den Hende, C., Deprez, P., Nuytten, J. and Oyaert, W. (1986) Noninsulin dependent diabetes mellitus in a horse. Equine vet. J. 18, 145-146.
36. Nathan, D.M., Buse, J.B., Davidson, M.B., Ferrannini, E., Holman, R.R., Sherwin, R. and Zinman, B. (2008) Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 31, 173-175.
37. Phillipe, J. and Raccah, D. (2009) Treating type 2 diabetes: how safe are current therapeutic agents? Int. J. Clin. Pract. 63, 221-232.
38. Pratt, S.E., Geor, R.J. and McCutcheon, L.J. (2006) Effects of dietary energy source and physical conditioning on insulin sensitivity and glucose tolerance in Standardbred horses. Equine vet. J., Suppl. 36, 579-584.
39. Ralston, S.L. (2002) Insulin and glucose regulation. Vet. Clin. N. Am.: Equine Pract. 18, 295-304.
40. Reeves, H.J., Lees, R. and McGowan, C.M. (2001) Measurement of basal serum insulin concentration in the diagnosis of Cushing's disease in ponies. Vet. Rec. 149, 449-452.
41. Riggs, W.L. (1972) Diabetes mellitus secondary to chronic necrotizing pancreatitis in a pony. Southwest Vet. 25, 149-152.
42. Rijnen, K.E.P.M. and van der Kolk, J.J. (2003) Determination of reference range values indicative of glucose metabolism and insulin resistance by use of glucose clamp techniques in horses and ponies. Am. J. vet. Res. 64, 1260-1264.
43. Ruoff, W.W., Baker, D.C., Morgan, S.J. and Abbitt, B. (1986) Type II diabetes mellitus in a horse. Equine vet. J. 18, 143-144.
44. Tasker, J.B., Whiteman, C.E. and Martin, B.R. (1966) Diabetes mellitus in the horse. J. Am. vet. med. Ass. 149, 393-399.
45. Tiley, H.A., Geor, R.J. and McCutcheon, L.J. (2007) Effects of dexamethasone on glucose dynamics and insulin sensitivity in healthy horses. Am. J. vet. Res. 68, 753-759.
46. Tóth, F., Frank, N., Elliott, S.B., Geor, R.J. and Boston, R.C. (2008) Effects of an intravenous endotoxin challenge on glucose and insulin dynamics in horses. Am. J. vet. Res. 69, 82-88.
47. Tóth, F., Frank, N., Elliott, S.B., Perdue, K., Geor, R.J. and Boston, R.C. (2009) Optimisation of the frequently sampled intravenous glucose tolerance test to reduce urinary glucose spilling in horses. Equine vet. J. 41, 844-851.
48. Treiber, K.H., Kronfeld, D.S. and Geor, R.J. (2006a) Insulin resistance in equids: possible role in laminitis. J. Nutr. 136, 2094S-2098S.
49. Treiber, K.H., Hess, T.M., Kronfeld, D.S., Boston, R.C., Geor, R.J., Friere, M., Silva, A.M. and Harris, P.A. (2006b) Glucose dynamics during exercise: dietary energy sources affect minimal model parameters in trained Arabian geldings during endurance exercise. Equine vet. J., Suppl. 36, 631-636.
50. Treiber, K.H., Kronfeld, D.S., Hess, T.M., Boston, R.C. and Harris, P.A. (2005) Use of proxies and reference quintiles obtained from minimal model analysis for determination of insulin sensitivity and pancreatic beta-cell responsiveness in horses. Am. J. vet. Res. 66, 2114-2121.
51. van der Kolk, J.H., Kalsbeek, H.C., van Garderen, E., Wensing, T. and Breukink, H.J. (1993) Equine pituitary neoplasia: a clinical report of 21 cases (1990-1992). Vet. Rec. 133, 594-597.
52. van der Kolk, J.H., Rijnen, K.E., Rey, F., de Graaf-Roelfsema, E., Grinwis, G.C. and Wijnberg, I.D. (2005) Evaluation of glucose metabolism in three horses with lower motor neuron degeneration. Am. J. vet. Res. 66, 271-276.
53. Vick, M.M., Sessions, D.R., Murphy, B.A., Kennedy, E.L., Reedy, S.E. and Fitzgerald, B.P. (2006) Obesity is associated with altered metabolic and reproductive activity in the mare: effects of metformin on insulin sensitivity and reproductive cyclicity. Reprod. Fertil. Dev. 18, 609-617.
54. Wallace, T.M. and Matthews, D.R. (2002) The assessment of insulin resistance in man. Diabet. Med. 19, 527-534.
55. Weyer, C., Tataranni, P.A., Bogardus, C. and Pratley, R.E. (2001) Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. Diabetes Care 24, 89-94.